Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated:  4/12/2016
Greenville Hospital System
mi
from
Greenville, SC
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated: 4/12/2016
Greenville Hospital System
mi
from
Greenville, SC
Click here to add this to my saved trials
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated:  4/12/2016
Cardiothoracic & Vascular Surgeons
mi
from
Austin, TX
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated: 4/12/2016
Cardiothoracic & Vascular Surgeons
mi
from
Austin, TX
Click here to add this to my saved trials
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated:  4/12/2016
Methodist Medical Center
mi
from
Dallas, TX
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated: 4/12/2016
Methodist Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated:  4/12/2016
Dallas VA Medical Center
mi
from
Dallas, TX
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated: 4/12/2016
Dallas VA Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated:  4/12/2016
Sentara Vascular Specialists
mi
from
Norfolk, VA
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated: 4/12/2016
Sentara Vascular Specialists
mi
from
Norfolk, VA
Click here to add this to my saved trials
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated:  4/12/2016
Hospital Virgen de la Salud
mi
from
Toledo,
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated: 4/12/2016
Hospital Virgen de la Salud
mi
from
Toledo,
Click here to add this to my saved trials
Safety Study of Pyridostigmine in Heart Failure
Augmentation of Parasympathetic Signaling With Pyridostigmine in Heart Failure
Status: Enrolling
Updated:  4/13/2016
New York University Langone Medical Center
mi
from
New York, NY
Safety Study of Pyridostigmine in Heart Failure
Augmentation of Parasympathetic Signaling With Pyridostigmine in Heart Failure
Status: Enrolling
Updated: 4/13/2016
New York University Langone Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Dynamic Thoracic Impedance as a Marker for Heart Failure Decompensation
Dynamic Thoracic Impedance as a Marker for Heart Failure Decompensation: A Pilot Trial of the "Dynamic Thoracic Impedance Bed Rest Test"
Status: Enrolling
Updated:  4/13/2016
University of Kansas Medical Center
mi
from
Kansas City, KA
Dynamic Thoracic Impedance as a Marker for Heart Failure Decompensation
Dynamic Thoracic Impedance as a Marker for Heart Failure Decompensation: A Pilot Trial of the "Dynamic Thoracic Impedance Bed Rest Test"
Status: Enrolling
Updated: 4/13/2016
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
To Evaluate the Safety and Efficacy for GORE TAG Thoracic Endoprosthesis in the Treatment of Thoracic Aortic Disease
A Clinical Study of the TAG Thoracic Endoprosthesis in the Treatment of Thoracic Aortic Diseases for Non-Surgical Candidates Under the Physician Sponsored IDE.
Status: Enrolling
Updated:  4/13/2016
Stanford University School of Medicine
mi
from
Stanford, CA
To Evaluate the Safety and Efficacy for GORE TAG Thoracic Endoprosthesis in the Treatment of Thoracic Aortic Disease
A Clinical Study of the TAG Thoracic Endoprosthesis in the Treatment of Thoracic Aortic Diseases for Non-Surgical Candidates Under the Physician Sponsored IDE.
Status: Enrolling
Updated: 4/13/2016
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Evaluation of Exercise Treadmill Test Indices in Patients With Cardiovascular Disease
Evaluation of Exercise Treadmill Test Indices in Patients With Cardiovascular Disease
Status: Enrolling
Updated:  4/15/2016
Novartis Investigative Site
mi
from
Jacksonville, FL
Evaluation of Exercise Treadmill Test Indices in Patients With Cardiovascular Disease
Evaluation of Exercise Treadmill Test Indices in Patients With Cardiovascular Disease
Status: Enrolling
Updated: 4/15/2016
Novartis Investigative Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Evaluation of Exercise Treadmill Test Indices in Patients With Cardiovascular Disease
Evaluation of Exercise Treadmill Test Indices in Patients With Cardiovascular Disease
Status: Enrolling
Updated:  4/15/2016
Novartis
mi
from
New York, NY
Evaluation of Exercise Treadmill Test Indices in Patients With Cardiovascular Disease
Evaluation of Exercise Treadmill Test Indices in Patients With Cardiovascular Disease
Status: Enrolling
Updated: 4/15/2016
Novartis
mi
from
New York, NY
Click here to add this to my saved trials
The Congestive Heart Failure Adherence Redesign Trial
Reduction in Hospitalizations in Low-Income Patients With Heart Failure
Status: Enrolling
Updated:  4/15/2016
Rush University Medical Center
mi
from
Chicago, IL
The Congestive Heart Failure Adherence Redesign Trial
Reduction in Hospitalizations in Low-Income Patients With Heart Failure
Status: Enrolling
Updated: 4/15/2016
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Examining the Link Between Trace Elements and Cardiovascular Disease Risk Factors in Young Adults
Trace Elements and CVD Risk Factors Among Young Adults
Status: Enrolling
Updated:  4/15/2016
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Examining the Link Between Trace Elements and Cardiovascular Disease Risk Factors in Young Adults
Trace Elements and CVD Risk Factors Among Young Adults
Status: Enrolling
Updated: 4/15/2016
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
THE GIRAFFE Study: Genomic Risk Markers for Atrial Fibrillation Following Extended Cardiac Rhythm Monitoring
This Study Will Investigate the Association Between a Set of Single Nucleotide Polymorphisms (SNPs) and Atrial Fibrillation in Patients at High Risk of Developing Atrial Fibrillation. The SNPs Investigated Will Have Been Previously Shown to be Associated With the Atrial Fibrillation.
Status: Enrolling
Updated:  4/18/2016
Scripps Clinic
mi
from
La Jolla, CA
THE GIRAFFE Study: Genomic Risk Markers for Atrial Fibrillation Following Extended Cardiac Rhythm Monitoring
This Study Will Investigate the Association Between a Set of Single Nucleotide Polymorphisms (SNPs) and Atrial Fibrillation in Patients at High Risk of Developing Atrial Fibrillation. The SNPs Investigated Will Have Been Previously Shown to be Associated With the Atrial Fibrillation.
Status: Enrolling
Updated: 4/18/2016
Scripps Clinic
mi
from
La Jolla, CA
Click here to add this to my saved trials
Evaluation of the Samsung LABGEO IVD-A20 CHF Test in a Point-of-Care Setting
Evaluation of the Samsung LABGEO IVD-A20 CHF Test in a Point-of-Care Setting
Status: Enrolling
Updated:  4/18/2016
University of Maryland
mi
from
Baltimore, MD
Evaluation of the Samsung LABGEO IVD-A20 CHF Test in a Point-of-Care Setting
Evaluation of the Samsung LABGEO IVD-A20 CHF Test in a Point-of-Care Setting
Status: Enrolling
Updated: 4/18/2016
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Evaluation of the Samsung LABGEO IVD-A20 CHF Test in a Point-of-Care Setting
Evaluation of the Samsung LABGEO IVD-A20 CHF Test in a Point-of-Care Setting
Status: Enrolling
Updated:  4/18/2016
Minneapolis Medical Research Foundation
mi
from
Minneapolis, MN
Evaluation of the Samsung LABGEO IVD-A20 CHF Test in a Point-of-Care Setting
Evaluation of the Samsung LABGEO IVD-A20 CHF Test in a Point-of-Care Setting
Status: Enrolling
Updated: 4/18/2016
Minneapolis Medical Research Foundation
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Evaluation of the Samsung LABGEO IVD-A20 CHF Test in a Point-of-Care Setting
Evaluation of the Samsung LABGEO IVD-A20 CHF Test in a Point-of-Care Setting
Status: Enrolling
Updated:  4/18/2016
Manassas Clinical Research Center
mi
from
Manassas, VA
Evaluation of the Samsung LABGEO IVD-A20 CHF Test in a Point-of-Care Setting
Evaluation of the Samsung LABGEO IVD-A20 CHF Test in a Point-of-Care Setting
Status: Enrolling
Updated: 4/18/2016
Manassas Clinical Research Center
mi
from
Manassas, VA
Click here to add this to my saved trials
Effects of Aprotinin During Cardiac Surgery/Long Term Death Rates
Systemic Effects of Aprotinin During Cardiac Surgery/ Long Term Death Rates
Status: Enrolling
Updated:  4/18/2016
SUNY Upstate Medical University
mi
from
Syracuse, NY
Effects of Aprotinin During Cardiac Surgery/Long Term Death Rates
Systemic Effects of Aprotinin During Cardiac Surgery/ Long Term Death Rates
Status: Enrolling
Updated: 4/18/2016
SUNY Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
University of Florida
mi
from
Gainesville, FL
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
Georgia Health Sciences University
mi
from
Augusta, GA
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
Georgia Health Sciences University
mi
from
Augusta, GA
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
Tulane University Health Science Center
mi
from
New Orleans, LA
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
Tulane University Health Science Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
University of Maryland School of Medicine
mi
from
Baltimore, MD
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
University of Maryland School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
Henry Ford Hospital
mi
from
Detroit, MI
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
Mayo Clinic College of Medicine
mi
from
Rochester, MN
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
Mayo Clinic College of Medicine
mi
from
Rochester, MN
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
Montefiore Medical Center
mi
from
Bronx, NY
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
Duke University
mi
from
Durham, NC
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
Vanderbilt University
mi
from
Nashville, TN
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
University of Texas Medical Branch
mi
from
Galveston, TX
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
University of Texas Medical Branch
mi
from
Galveston, TX
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
Intermountain Medical Center
mi
from
Murray, UT
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
Intermountain Medical Center
mi
from
Murray, UT
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
University of Utah Health Care
mi
from
Salt Lake City, UT
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
University of Utah Health Care
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
Marshfield Clinical Research Foundation
mi
from
Marshfield, WI
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
Marshfield Clinical Research Foundation
mi
from
Marshfield, WI
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
University of California at San Francisco
mi
from
San Francisco, CA
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
Washington University School of Medicine
mi
from
St. Louis, MO
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
Washington University School of Medicine
mi
from
St. Louis, MO
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
Mount Sinai School of Medicine
mi
from
New York, NY
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
High-Dose Aldactone for Treatment of Diuretic Resistant Heart Failure
High-Dose Aldactone for Treatment of Diuretic Resistant Heart Failure
Status: Enrolling
Updated:  4/19/2016
University Hospital
mi
from
San Antonio, TX
High-Dose Aldactone for Treatment of Diuretic Resistant Heart Failure
High-Dose Aldactone for Treatment of Diuretic Resistant Heart Failure
Status: Enrolling
Updated: 4/19/2016
University Hospital
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure
A Phase IIa Randomized Study to Assess the Safety, Tolerability, and Preliminary Efficacy of a Single Intravenous Dose of Ischemia-tolerant Allogeneic Mesenchymal Bone Marrow Cells to Subjects With Non-ischemic Heart Failure
Status: Enrolling
Updated:  4/19/2016
MedStar Washington Hospital Center
mi
from
Washington,
A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure
A Phase IIa Randomized Study to Assess the Safety, Tolerability, and Preliminary Efficacy of a Single Intravenous Dose of Ischemia-tolerant Allogeneic Mesenchymal Bone Marrow Cells to Subjects With Non-ischemic Heart Failure
Status: Enrolling
Updated: 4/19/2016
MedStar Washington Hospital Center
mi
from
Washington,
Click here to add this to my saved trials
A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure
A Phase IIa Randomized Study to Assess the Safety, Tolerability, and Preliminary Efficacy of a Single Intravenous Dose of Ischemia-tolerant Allogeneic Mesenchymal Bone Marrow Cells to Subjects With Non-ischemic Heart Failure
Status: Enrolling
Updated:  4/19/2016
Emory University Hospital
mi
from
Atlanta, GA
A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure
A Phase IIa Randomized Study to Assess the Safety, Tolerability, and Preliminary Efficacy of a Single Intravenous Dose of Ischemia-tolerant Allogeneic Mesenchymal Bone Marrow Cells to Subjects With Non-ischemic Heart Failure
Status: Enrolling
Updated: 4/19/2016
Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure
A Phase IIa Randomized Study to Assess the Safety, Tolerability, and Preliminary Efficacy of a Single Intravenous Dose of Ischemia-tolerant Allogeneic Mesenchymal Bone Marrow Cells to Subjects With Non-ischemic Heart Failure
Status: Enrolling
Updated:  4/19/2016
Northwestern University Centers for Heart Failure Therapy
mi
from
Chicago, IL
A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure
A Phase IIa Randomized Study to Assess the Safety, Tolerability, and Preliminary Efficacy of a Single Intravenous Dose of Ischemia-tolerant Allogeneic Mesenchymal Bone Marrow Cells to Subjects With Non-ischemic Heart Failure
Status: Enrolling
Updated: 4/19/2016
Northwestern University Centers for Heart Failure Therapy
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure
A Phase IIa Randomized Study to Assess the Safety, Tolerability, and Preliminary Efficacy of a Single Intravenous Dose of Ischemia-tolerant Allogeneic Mesenchymal Bone Marrow Cells to Subjects With Non-ischemic Heart Failure
Status: Enrolling
Updated:  4/19/2016
Stony Brook Heart Institute
mi
from
Stony Brook, NY
A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure
A Phase IIa Randomized Study to Assess the Safety, Tolerability, and Preliminary Efficacy of a Single Intravenous Dose of Ischemia-tolerant Allogeneic Mesenchymal Bone Marrow Cells to Subjects With Non-ischemic Heart Failure
Status: Enrolling
Updated: 4/19/2016
Stony Brook Heart Institute
mi
from
Stony Brook, NY
Click here to add this to my saved trials
A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure
A Phase IIa Randomized Study to Assess the Safety, Tolerability, and Preliminary Efficacy of a Single Intravenous Dose of Ischemia-tolerant Allogeneic Mesenchymal Bone Marrow Cells to Subjects With Non-ischemic Heart Failure
Status: Enrolling
Updated:  4/19/2016
Hospital of the University of Pennsylvania, Heart Failure and Transplant Program
mi
from
Philedelphia, PA
A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure
A Phase IIa Randomized Study to Assess the Safety, Tolerability, and Preliminary Efficacy of a Single Intravenous Dose of Ischemia-tolerant Allogeneic Mesenchymal Bone Marrow Cells to Subjects With Non-ischemic Heart Failure
Status: Enrolling
Updated: 4/19/2016
Hospital of the University of Pennsylvania, Heart Failure and Transplant Program
mi
from
Philedelphia, PA
Click here to add this to my saved trials
Stereotactic Body Radiotherapy for Spine Tumors
Phase IV Trial Evaluating the Use of Stereotactic Body Radiotherapy for the Treatment of Spine Metastases and Primary Spine Tumors
Status: Enrolling
Updated:  4/20/2016
St. John's Mercy Medical Center
mi
from
St. Louis, MO
Stereotactic Body Radiotherapy for Spine Tumors
Phase IV Trial Evaluating the Use of Stereotactic Body Radiotherapy for the Treatment of Spine Metastases and Primary Spine Tumors
Status: Enrolling
Updated: 4/20/2016
St. John's Mercy Medical Center
mi
from
St. Louis, MO
Click here to add this to my saved trials
Safety Study of PZ-128 in Subjects With Multiple Coronary Artery Disease Risk Factors
Demonstration of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Antiplatelet Effect of PZ-128 in Subjects With Multiple Coronary Artery Disease Risk Factors
Status: Enrolling
Updated:  4/20/2016
Sinai Hospital of Baltimore (Sinai Center for Thrombosis Research)
mi
from
Baltimore, MD
Safety Study of PZ-128 in Subjects With Multiple Coronary Artery Disease Risk Factors
Demonstration of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Antiplatelet Effect of PZ-128 in Subjects With Multiple Coronary Artery Disease Risk Factors
Status: Enrolling
Updated: 4/20/2016
Sinai Hospital of Baltimore (Sinai Center for Thrombosis Research)
mi
from
Baltimore, MD
Click here to add this to my saved trials
Evaluation of the Short and Long Term Performance and Clinical Outcomes of the Crux Vena Cava Filter System
Volcano Crux Vena Cava Filter Registry
Status: Enrolling
Updated:  4/21/2016
Northside Vascular Surgery
mi
from
Atlanta, GA
Evaluation of the Short and Long Term Performance and Clinical Outcomes of the Crux Vena Cava Filter System
Volcano Crux Vena Cava Filter Registry
Status: Enrolling
Updated: 4/21/2016
Northside Vascular Surgery
mi
from
Atlanta, GA
Click here to add this to my saved trials
Evaluation of the Short and Long Term Performance and Clinical Outcomes of the Crux Vena Cava Filter System
Volcano Crux Vena Cava Filter Registry
Status: Enrolling
Updated:  4/21/2016
Rex Healthcare
mi
from
Raleigh, NC
Evaluation of the Short and Long Term Performance and Clinical Outcomes of the Crux Vena Cava Filter System
Volcano Crux Vena Cava Filter Registry
Status: Enrolling
Updated: 4/21/2016
Rex Healthcare
mi
from
Raleigh, NC
Click here to add this to my saved trials
Evaluation of the Short and Long Term Performance and Clinical Outcomes of the Crux Vena Cava Filter System
Volcano Crux Vena Cava Filter Registry
Status: Enrolling
Updated:  4/21/2016
Turkey Creek Medical Center
mi
from
Knoxville, TN
Evaluation of the Short and Long Term Performance and Clinical Outcomes of the Crux Vena Cava Filter System
Volcano Crux Vena Cava Filter Registry
Status: Enrolling
Updated: 4/21/2016
Turkey Creek Medical Center
mi
from
Knoxville, TN
Click here to add this to my saved trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
Moblie, AL
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
Moblie, AL
Click here to add this to my saved trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
Costa Mesa, CA
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
Fresno, CA
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials